139 related articles for article (PubMed ID: 12935991)
41. Graft-versus-host disease-like features in mycophenolate mofetil-related colitis.
Papadimitriou JC; Drachenberg CB; Beskow CO; Cangro C; Wiland A; Klassen D; Weir M; Bartlett S
Transplant Proc; 2001 May; 33(3):2237-8. PubMed ID: 11377513
[No Abstract] [Full Text] [Related]
42. Successful use of mycophenolate mofetil to treat severe chronic urticaria in a patient intolerant to ciclosporin.
Raghavendran RR; Humphreys F; Kaur MR
Clin Exp Dermatol; 2014 Jan; 39(1):68-9. PubMed ID: 23692555
[No Abstract] [Full Text] [Related]
43. Mycophenolate mofetil in myasthenia gravis: the unanswered question.
Phan C; Sanders DB; Siddiqi ZA
Expert Opin Pharmacother; 2008 Oct; 9(14):2545-51. PubMed ID: 18778192
[TBL] [Abstract][Full Text] [Related]
44. Mycophenolate mofetil during pregnancy: some words of caution.
Vento M; Perez Aytes A; Ledo A; Boso V; Carey JC
Pediatrics; 2008 Jul; 122(1):184-5. PubMed ID: 18596003
[No Abstract] [Full Text] [Related]
45. Mycophenolate mofetil is effective only for involved skin in the treatment for steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Hattori K; Doki N; Kurosawa S; Hino Y; Yamamoto K; Sakaguchi M; Harada K; Ikegawa S; Shingai N; Senoo Y; Igarashi A; Najima Y; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
Ann Hematol; 2017 Feb; 96(2):319-321. PubMed ID: 27766393
[No Abstract] [Full Text] [Related]
46. A case with Listeria meningitis during administration of mycophenolate mofetil for pemphigus vulgaris.
Akyol M; Ozçelik S; Engin A; Ozel l ahin G
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1447-8. PubMed ID: 17958877
[No Abstract] [Full Text] [Related]
47. Open-Label, Multicenter Phase II Study of Combination Therapy of Imatinib Mesylate and Mycophenolate Mofetil in Pediatric Patients with Steroid-Refractory Sclerotic/Fibrotic Type Chronic Graft-versus-Host Disease.
Choi JY; Kim H; Baek HJ; Kook H; Lee JM; Kim BK; An HY; Hong KT; Shin HY; Kang HJ
Transplant Cell Ther; 2021 Nov; 27(11):925.e1-925.e7. PubMed ID: 34314892
[TBL] [Abstract][Full Text] [Related]
48. Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability.
Meriggioli MN; Ciafaloni E; Al-Hayk KA; Rowin J; Tucker-Lipscomb B; Massey JM; Sanders DB
Neurology; 2003 Nov; 61(10):1438-40. PubMed ID: 14638974
[TBL] [Abstract][Full Text] [Related]
49. Mycophenolate in dermatology.
Liu V; Mackool BT
J Dermatolog Treat; 2003 Dec; 14(4):203-11. PubMed ID: 14660264
[TBL] [Abstract][Full Text] [Related]
50. Mycophenolate mofetil to the rescue in autoimmune hepatitis: a fresh sprout on the decision tree.
Czaja AJ
J Hepatol; 2009 Jul; 51(1):8-10. PubMed ID: 19446910
[No Abstract] [Full Text] [Related]
51. Mycophenolate mofetil therapy in a child with Churg-Strauss syndrome.
Demircin G; Baysun S; Bülbül M; Erdoğan O; Oner A
Pediatr Int; 2010 Jun; 52(3):e164-6. PubMed ID: 20723119
[No Abstract] [Full Text] [Related]
52. Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy.
Gorson KC; Amato AA; Ropper AH
Neurology; 2004 Aug; 63(4):715-7. PubMed ID: 15326250
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.
Martin PJ; Storer BE; Rowley SD; Flowers ME; Lee SJ; Carpenter PA; Wingard JR; Shaughnessy PJ; DeVetten MP; Jagasia M; Fay JW; van Besien K; Gupta V; Kitko C; Johnston LJ; Maziarz RT; Arora M; Jacobson PA; Weisdorf D
Blood; 2009 May; 113(21):5074-82. PubMed ID: 19270260
[TBL] [Abstract][Full Text] [Related]
54. Refractory Waldenström's macroglobulinaemia responsive to 2-chlorodeoxyadenosine and mycophenolate mofetil.
Gladstone DE
Leuk Res; 2008 Sep; 32(9):1487-8. PubMed ID: 18378308
[No Abstract] [Full Text] [Related]
55. Mycophenolate mofetil use in the treatment of noninfectious uveitis.
Klisovic DD
Dev Ophthalmol; 2012; 51():57-62. PubMed ID: 22517204
[TBL] [Abstract][Full Text] [Related]
56. Cervical and vaginal cancer in a woman with chronic graft-versus-host disease.
Bolla D; Ruhstaller T; Diener PA; Lang F; Hornung R
Int J Gynaecol Obstet; 2011 Aug; 114(2):159-60. PubMed ID: 21669422
[No Abstract] [Full Text] [Related]
57. Severe, refractory type II essential mixed cryoglobulinemia treated with 2-chlorodeoxyadenosine and mycophenolate mofetil.
Gladstone DE; Golightly MG; Zamkoff KW
Rheumatol Int; 2005 Oct; 25(8):635-6. PubMed ID: 15703955
[No Abstract] [Full Text] [Related]
58. Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.
Martin PJ; Storer BE; Carpenter PA; Couriel DR; Flowers ME; Gupta V; Hsu JW; Jagasia M; Kitko CL; Maziarz RT; Rowley SD; Shaughnessy PJ; van Besien K; Weisdorf D; Lee SJ
Biol Blood Marrow Transplant; 2011 Jan; 17(1):124-32. PubMed ID: 20601033
[TBL] [Abstract][Full Text] [Related]
59. Long-standing refractory polymyositis responding to mycophenolate mofetil: a case report and review of the literature.
Caramaschi P; Volpe A; Carletto A; Bambara LM; Biasi D
Clin Rheumatol; 2007 Oct; 26(10):1795-6. PubMed ID: 17225929
[TBL] [Abstract][Full Text] [Related]
60. Mycophenolate mofetil in extensive Alopecia areata: no effect in seven patients.
Köse O; Safali M; Bulent Tastan H; Gur AR
Dermatology; 2004; 209(1):69-70. PubMed ID: 15237274
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
